![Peter Falk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Falk
Corporate Officer/Principal bij Sahlgrenska University
Oorsprong van het eerstegraads netwerk van Peter Falk
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Sahlgrenska University
6
| College/University | Other Consumer Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peter Falk via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Gothenburg | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Director/Board Member Doctorate Degree | |
OREXO AB | Pharmaceuticals: Major | Chairman | |
Glactone Pharma AB
![]() Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chairman | |
CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Goldwater Sweden AB | Director/Board Member | ||
BD Medical Consulting AB | Director/Board Member | ||
J N K Clothing Co. AB | Corporate Officer/Principal | ||
PEXA AB | Medical Specialties | Director/Board Member | |
LIDDS AB | Pharmaceuticals: Major | Chairman | |
Glactone Pharma Development AB | Chairman | ||
Innoex AB | Chief Executive Officer | ||
Diaprost AB
![]() Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Stayble AB | Director/Board Member | ||
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Aqilion AB
![]() Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
Scandinavian CRI Holding AB | Director/Board Member | ||
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
ABLIVA AB | Pharmaceuticals: Major | Director/Board Member | |
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Lidds Pharma AB | Corporate Officer/Principal | ||
Innoext AB
![]() Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Miscellaneous Commercial Services | Chief Executive Officer | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chairman | |
Hammars Bryggeri AB
![]() Hammars Bryggeri AB Beverages: AlcoholicConsumer Non-Durables Hammars Bryggeri AB engages in brewery operations. It produces a wide range of soft drinks, water, and other cider beverages. The company was founded in 1904 and is headquartered in Hammar, Sweden. | Beverages: Alcoholic | Director/Board Member | |
Puls AB
![]() Puls AB Environmental ServicesIndustrial Services Puls AB is a Swedish company that specializes in sewage, industrial, and environmental services. Puls is located in Staffanstorp, Sweden and is known as the largest player in va maintenance in southern Sweden. The private company offers on-call assistance for a range of issues, including emergency stops in the drain and remediation after accidents. The company provides services such as sewage cleaning, wastewater flushing, and water blasting to clean tanks, cisterns, sheet metal, boat hulls, and more in an environmentally friendly manner. The company has a team of talented employees who specialize in water and wastewater services for tenant-owner associations, offering maintenance and emergency measures. | Environmental Services | Corporate Officer/Principal | |
ANAVEX LIFE SCIENCES CORP. | Biotechnology | Corporate Officer/Principal | |
Gabelli School of Business | College/University | Masters Business Admin | |
ECTIN RESEARCH AB | Biotechnology | Founder | |
Ivarsson Medical Research AB
![]() Ivarsson Medical Research AB Investment Banks/BrokersFinance Ivarsson Medical Research AB is a Swedish company that engages in the management and trading of securities. The CEO of the private company is Marie-Lois Ivarsson. | Investment Banks/Brokers | Chief Executive Officer | |
Medlys HB | Corporate Officer/Principal | ||
Tandaxessen i Sverige | Director/Board Member | ||
Brazilinvest AB | Director/Board Member | ||
Scandinavian Cri AB | Director/Board Member | ||
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
Biolipox AB
![]() Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
Ferrosan ApS
![]() Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Other | Chairman | |
Kabi Pharmacia | Chief Executive Officer | ||
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman | |
Ferrosan International A/S
![]() Ferrosan International A/S Pharmaceuticals: MajorHealth Technology Ferrosan International A/S engages in the manufacture and supply of consumer healthcare products and medical devices. The company was founded in 1920 and is headquartered in Moscow, Russia. | Pharmaceuticals: Major | Director/Board Member | |
Travenol AB | Chief Executive Officer | ||
Astra Pharmaceuticals Ltd.
![]() Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Astra Pharmaceuticals Ltd. manufactures & wholesales pharmaceutical products. The company was established in 1908 and is headquartered in London, GB | Pharmaceuticals: Major | Chief Executive Officer | |
MedCore AB
![]() MedCore AB Medical SpecialtiesHealth Technology MedCore AB operates as a medical technology company. It engages in the distribution of medical products. The company was founded in 2000 and is headquartered in Kista, Sweden. | Medical Specialties | Chairman | |
Stockholm School of Economics | College/University | Graduate Degree | |
Tubulus AB | Chairman |
Statistieken
Internationaal
Zweden | 41 |
Denemarken | 5 |
Verenigde Staten | 4 |
Verenigd Koninkrijk | 3 |
Rusland | 2 |
Sectoraal
Health Technology | 25 |
Consumer Services | 5 |
Commercial Services | 4 |
Finance | 3 |
Consumer Non-Durables | 2 |
Operationeel
Director/Board Member | 29 |
Chairman | 21 |
Corporate Officer/Principal | 15 |
Chief Executive Officer | 9 |
Independent Dir/Board Member | 6 |
Sterkste connecties
- Beurs
- Insiders
- Peter Falk
- Bedrijfsconnecties